Source: Eur Respir J 2010; 36: 712-713



Rating:

Share or cite this content

Citations should be made in the following way:
Pletz M.W., Welte T., Klugman K.P.. The paradox in pneumococcal serotypes: highly invasive does not mean highly lethal. Eur Respir J 2010; 36: 712-713

Member's Comments

No comment yet.

Related content which might interest you: The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Evolutionary trend of invasive pneumococcal disease according to serotypes Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021 Year: 2022 Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010 Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types Source: Eur Respir J 2014; 44: 1646-1657 Year: 2014 Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013 Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Characteristics of patients with serotype 5 pneumococcal pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 How can we reduce the mortality of invasive pneumococcal disease? Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine Year: 2013 How can we reduce the mortality of invasive pneumococcal disease? Source: Eur Respir Rev 2012; 21: 6-7 Year: 2012 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia Source: Eur Respir J 2015; 45: 1632-1641 Year: 2015 Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population Source: Eur Respir J 2016; 48: 1492-1496 Year: 2016